|
| 36196007 | Maternal Periconceptional Folic Acid Supplementation and DNA Methylation Patterns in Adolescent Offspring. | J Nutr | 2023 |
| 35771716 | Method of Tissue Acquisition Affects Success of Comprehensive Genomic Profiling in Lung Cancer. | Arch Pathol Lab Med | 2023 |
| 36302175 | A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell Carcinoma. | Clin Cancer Res | 2023 |
| 36196007 | Maternal Periconceptional Folic Acid Supplementation and DNA Methylation Patterns in Adolescent Offspring. | J Nutr | 2023 |
| 36712882 | Genome-wide DNA methylation profiling in chronic lymphocytic leukaemia. | Front Genet | 2023 |
| 36776857 | RAGE contributes to allergen driven severe neutrophilic airway inflammation <i>via</i> NLRP3 inflammasome activation in mice. | Front Immunol | 2023 |
| 35771716 | Method of Tissue Acquisition Affects Success of Comprehensive Genomic Profiling in Lung Cancer. | Arch Pathol Lab Med | 2023 |
| 36712882 | Genome-wide DNA methylation profiling in chronic lymphocytic leukaemia. | Front Genet | 2023 |
| 36776857 | RAGE contributes to allergen driven severe neutrophilic airway inflammation <i>via</i> NLRP3 inflammasome activation in mice. | Front Immunol | 2023 |
| 36302175 | A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell Carcinoma. | Clin Cancer Res | 2023 |
| 34998597 | Molecular analysis of endometrial serous carcinoma reveals distinct clinicopathologic and genomic subgroups. | Gynecol Oncol | 2022 |
| 35749302 | Comprehensive Genomic Profiling of 274 Thymic Epithelial Tumors Unveils Oncogenic Pathways and Predictive Biomarkers. | Oncologist | 2022 |
| 36455002 | Kidney tumors associated with germline mutations of FH and SDHB show a CpG island methylator phenotype (CIMP). | PLoS One | 2022 |
| 34998597 | Molecular analysis of endometrial serous carcinoma reveals distinct clinicopathologic and genomic subgroups. | Gynecol Oncol | 2022 |
| 35749302 | Comprehensive Genomic Profiling of 274 Thymic Epithelial Tumors Unveils Oncogenic Pathways and Predictive Biomarkers. | Oncologist | 2022 |
| 36455002 | Kidney tumors associated with germline mutations of FH and SDHB show a CpG island methylator phenotype (CIMP). | PLoS One | 2022 |
| 32884129 | A pan-cancer analysis of PD-L1 immunohistochemistry and gene amplification, tumor mutation burden and microsatellite instability in 48,782 cases. | Mod Pathol | 2021 |
| 33904632 | Histiocytic and Dendritic Cell Sarcomas of Hematopoietic Origin Share Targetable Genomic Alterations Distinct from Follicular Dendritic Cell Sarcoma. | Oncologist | 2021 |
| 34282751 | Clinically Advanced Pheochromocytomas and Paragangliomas: A Comprehensive Genomic Profiling Study. | Cancers (Basel) | 2021 |
| 33527590 | Characterization of genetically defined sporadic and hereditary type 1 papillary renal cell carcinoma cell lines. | Genes Chromosomes Cancer | 2021 |
| 34215504 | Comprehensive genomic profiling of histologic subtypes of urethral carcinomas. | Urol Oncol | 2021 |
| 33840146 | Novel MEAF6-SUZ12 fusion in ossifying fibromyxoid tumor with unusual features. | Genes Chromosomes Cancer | 2021 |
| 33775530 | Comprehensive genomic profiling of metastatic collecting duct carcinoma, renal medullary carcinoma, and clear cell renal cell carcinoma. | Urol Oncol | 2021 |
| 34257540 | Landscape of Biomarkers in Non-small Cell Lung Cancer Using Comprehensive Genomic Profiling and PD-L1 Immunohistochemistry. | Pathol Oncol Res | 2021 |
| 32884129 | A pan-cancer analysis of PD-L1 immunohistochemistry and gene amplification, tumor mutation burden and microsatellite instability in 48,782 cases. | Mod Pathol | 2021 |
| 33314633 | Predictive Biomarkers for Immune Checkpoint Inhibitors in Metastatic Breast Cancer. | Cancer Med | 2021 |
| 33077920 | Recurrent urothelial carcinoma-like FGFR3 genomic alterations in malignant Brenner tumors of the ovary. | Mod Pathol | 2021 |
| 34626187 | Circulating Cell-Free DNA Yield and Circulating-Tumor DNA Quantity from Liquid Biopsies of 12â¿¿139 Cancer Patients. | Clin Chem | 2021 |
| 34379803 | Contrasting genomic profiles from metastatic sites, primary tumors, and liquid biopsies of advanced prostate cancer. | Cancer | 2021 |
| 33904632 | Histiocytic and Dendritic Cell Sarcomas of Hematopoietic Origin Share Targetable Genomic Alterations Distinct from Follicular Dendritic Cell Sarcoma. | Oncologist | 2021 |
| 33840146 | Novel MEAF6-SUZ12 fusion in ossifying fibromyxoid tumor with unusual features. | Genes Chromosomes Cancer | 2021 |
| 33775530 | Comprehensive genomic profiling of metastatic collecting duct carcinoma, renal medullary carcinoma, and clear cell renal cell carcinoma. | Urol Oncol | 2021 |
| 33527590 | Characterization of genetically defined sporadic and hereditary type 1 papillary renal cell carcinoma cell lines. | Genes Chromosomes Cancer | 2021 |
| 34379803 | Contrasting genomic profiles from metastatic sites, primary tumors, and liquid biopsies of advanced prostate cancer. | Cancer | 2021 |
| 34626187 | Circulating Cell-Free DNA Yield and Circulating-Tumor DNA Quantity from Liquid Biopsies of 12â¿¿139 Cancer Patients. | Clin Chem | 2021 |
| 34215504 | Comprehensive genomic profiling of histologic subtypes of urethral carcinomas. | Urol Oncol | 2021 |
| 34282751 | Clinically Advanced Pheochromocytomas and Paragangliomas: A Comprehensive Genomic Profiling Study. | Cancers (Basel) | 2021 |
| 34257540 | Landscape of Biomarkers in Non-small Cell Lung Cancer Using Comprehensive Genomic Profiling and PD-L1 Immunohistochemistry. | Pathol Oncol Res | 2021 |
| 33314633 | Predictive Biomarkers for Immune Checkpoint Inhibitors in Metastatic Breast Cancer. | Cancer Med | 2021 |
| 33077920 | Recurrent urothelial carcinoma-like FGFR3 genomic alterations in malignant Brenner tumors of the ovary. | Mod Pathol | 2021 |
| 30025711 | Genomic Characterization of Testicular Germ Cell Tumors Relapsing After Chemotherapy. | Eur Urol Focus | 2020 |
| 31959546 | Comprehensive Assessment of Immuno-oncology Biomarkers in Adenocarcinoma, Urothelial Carcinoma, and Squamous-cell Carcinoma of the Bladder. | Eur Urol | 2020 |
| 32346591 | A sporadic gastric-type endocervical adenocarcinoma with endometrial involvement and bilateral ovarian metastasis, a case report. | Gynecol Oncol Rep | 2020 |
| 32706863 | Distinct DNA Methylation Signatures in Neuroendocrine Tumors Specific for Primary Site and Inherited Predisposition. | J Clin Endocrinol Metab | 2020 |
| 32923875 | Vulvar Squamous Cell Carcinoma: Comprehensive Genomic Profiling of HPV+ Versus HPV- Forms Reveals Distinct Sets of Potentially Actionable Molecular Targets. | JCO Precis Oncol | 2020 |
| 33024807 | Molecular profiling of mesonephric and mesonephric-like carcinomas of cervical, endometrial and ovarian origin. | Gynecol Oncol Rep | 2020 |
| 30025711 | Genomic Characterization of Testicular Germ Cell Tumors Relapsing After Chemotherapy. | Eur Urol Focus | 2020 |
| 31959546 | Comprehensive Assessment of Immuno-oncology Biomarkers in Adenocarcinoma, Urothelial Carcinoma, and Squamous-cell Carcinoma of the Bladder. | Eur Urol | 2020 |
| 33024807 | Molecular profiling of mesonephric and mesonephric-like carcinomas of cervical, endometrial and ovarian origin. | Gynecol Oncol Rep | 2020 |
| 32706863 | Distinct DNA Methylation Signatures in Neuroendocrine Tumors Specific for Primary Site and Inherited Predisposition. | J Clin Endocrinol Metab | 2020 |